Envestnet Asset Management Inc Catalyst Pharmaceuticals, Inc. Transaction History
Envestnet Asset Management Inc
- $326 Billion
- Q2 2025
A detailed history of Envestnet Asset Management Inc transactions in Catalyst Pharmaceuticals, Inc. stock. As of the latest transaction made, Envestnet Asset Management Inc holds 101,607 shares of CPRX stock, worth $2.09 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
101,607
Previous 78,195
29.94%
Holding current value
$2.09 Million
Previous $1.9 Million
16.24%
% of portfolio
0.0%
Previous 0.0%
Shares
10 transactions
Others Institutions Holding CPRX
# of Institutions
386Shares Held
103MCall Options Held
0Put Options Held
277K-
Black Rock Inc. New York, NY18.7MShares$384 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA8.77MShares$180 Million0.0% of portfolio
-
State Street Corp Boston, MA5.48MShares$112 Million0.0% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny3.25MShares$66.8 Million0.1% of portfolio
-
Morgan Stanley New York, NY3.18MShares$65.4 Million0.0% of portfolio
About CATALYST PHARMACEUTICALS, INC.
- Ticker CPRX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 102,820,000
- Market Cap $2.11B
- Description
- Catalyst Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on developing and commercializing therapies for people with rare debilitating, chronic neuromuscular, and neurological diseases in the United States. It offers Firdapse, an amifampridine phosphate tablets for the treatment of patients with lambert-eaton myasthe...